References

Note: This list of references is included to show the reader that the information on this Web site came from objective sources. The list includes clinical studies published in medical journals, informational Web sites and other sources.

  1. Drug cost per year for Flomax available at drugstore.com. Accessed July 24, 2007.
  2. Flomax, Hytrin, Cardura, Uroxatral, Proscar and Avodart prescribing information.
  3. Issa M, Marshall F. Contemporary Diagnosis and Management of Diseases of the Prostate. 3rd ed. Newtown, Pa:Handbooks in Healthcare Co;2005:109.
  4. American Medical Systems. GreenLight Laser Therapy Patient Education Brochure. Accessed July 26, 2007.
  5. American Medical Systems. Advantages of Green Light HPS Laser Therapy Brochure. Accessed July 26, 2007.
  6. PROSTIVA RF Therapy System User Guide Clinical Data. Safety information from System User Guide.
  7. Bruskewitz R, Issa MM, Roehrborn CG, et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998;159:1588-1594.
  8. Roehrborn CG, Issa MM, Bruskewitz RC, et al. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology 1998;51:415-421.
  9. Hill B, Belville W, Bruskewitz R, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004;171(pt 1):2336-2340.
  10. Zlotta A, Giannakopoulos X, Maehlum O, Ostrem T, Schulman C. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcomes up to five years from three centers. Eur Urol. 2003;44:89-93.
  11. Carson CC, Fay R, Meyer J, Stein BS. Improving patient satisfaction: BPH management strategies. Urology Times 2001;29(suppl):1-9.Hill B, Belville W, AUA Practice Guidelines Committee.
  12. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170(Pt 1): 530-547. Accessed July 26, 2007.